Chemoradiotherapy and SHR-1701 in Patients With Unresectable Gastric Cancer

NCT07689851 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer (GC)
Gastroesophageal Junction Adenocarcinoma

Interventions

DRUG: COPOX
RADIATION: Radiotherapy
BIOLOGICAL: SHR-1701

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Collaborators

[object Object]